Mürvet Yılmaz

460 total citations
33 papers, 286 citations indexed

About

Mürvet Yılmaz is a scholar working on Nephrology, Molecular Biology and Oncology. According to data from OpenAlex, Mürvet Yılmaz has authored 33 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Mürvet Yılmaz's work include Renal Diseases and Glomerulopathies (6 papers), Dialysis and Renal Disease Management (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers). Mürvet Yılmaz is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), Dialysis and Renal Disease Management (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers). Mürvet Yılmaz collaborates with scholars based in Türkiye, United States and Cambodia. Mürvet Yılmaz's co-authors include Özlem Harmankaya, S. Seber, Ayşim Özağarı, Abdülkadir Ünsal, Ekrem Kara, Şemsi Nur Karabela, Fevziye Kabukçuoğlu, Canan Alkım, Dede Şit and Selda Çelik and has published in prestigious journals such as SHILAP Revista de lepidopterología, Osteoporosis International and Nephrology Dialysis Transplantation.

In The Last Decade

Mürvet Yılmaz

28 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mürvet Yılmaz Türkiye 12 110 72 55 43 40 33 286
Xiaoqiang Ding China 10 242 2.2× 107 1.5× 51 0.9× 44 1.0× 26 0.7× 33 446
Yoshiro Fujita Japan 10 81 0.7× 59 0.8× 65 1.2× 62 1.4× 24 0.6× 42 351
David Metz United States 11 88 0.8× 27 0.4× 23 0.4× 70 1.6× 98 2.5× 19 360
Richard J. Johnson Australia 8 113 1.0× 86 1.2× 24 0.4× 20 0.5× 12 0.3× 24 365
Nuri Barış Hasbal Türkiye 11 112 1.0× 44 0.6× 41 0.7× 29 0.7× 17 0.4× 44 336
Sinan Trabulus Türkiye 11 113 1.0× 68 0.9× 54 1.0× 35 0.8× 17 0.4× 59 381
José Carlos Peña Mexico 11 203 1.8× 90 1.3× 45 0.8× 30 0.7× 26 0.7× 35 413
Li Luo China 10 33 0.3× 31 0.4× 30 0.5× 49 1.1× 21 0.5× 36 302
Richard Hull United Kingdom 8 146 1.3× 66 0.9× 30 0.5× 15 0.3× 18 0.5× 18 361
Sam James United States 8 312 2.8× 118 1.6× 26 0.5× 49 1.1× 25 0.6× 12 442

Countries citing papers authored by Mürvet Yılmaz

Since Specialization
Citations

This map shows the geographic impact of Mürvet Yılmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mürvet Yılmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mürvet Yılmaz more than expected).

Fields of papers citing papers by Mürvet Yılmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mürvet Yılmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mürvet Yılmaz. The network helps show where Mürvet Yılmaz may publish in the future.

Co-authorship network of co-authors of Mürvet Yılmaz

This figure shows the co-authorship network connecting the top 25 collaborators of Mürvet Yılmaz. A scholar is included among the top collaborators of Mürvet Yılmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mürvet Yılmaz. Mürvet Yılmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Karabela, Şemsi Nur, et al.. (2022). Can systemic immune inflammation index at admission predict in-hospital mortality in chronic kidney disease patients with SARS-CoV-2 infection?. Nefrología (English Edition). 42(5). 549–558. 7 indexed citations
3.
Yılmaz, Mürvet, et al.. (2022). Prognostic value of histopathological scoring and grading in patients with renal AA amyloidosis. International Urology and Nephrology. 54(10). 2591–2597. 3 indexed citations
4.
Çelik, Selda, et al.. (2022). Could systemic immune inflammation index be a new parameter for diagnosis and disease activity assessment in systemic lupus erythematosus?. International Urology and Nephrology. 55(1). 211–216. 21 indexed citations
5.
Karaosmanoğlu, Hayat Kumbasar, et al.. (2021). COVID-19 in hemodialysis patients: a single-center experience in Istanbul. International Urology and Nephrology. 53(11). 2385–2397. 3 indexed citations
6.
7.
Apaydın, Süheyla, et al.. (2017). SP082P-ANCA (POSITIVE)VASCULITIS FOLLOWING INTRAVESICAL INSTILLATION OF BACILLUS CALMETTE-GUERIN. Nephrology Dialysis Transplantation. 32(suppl_3). iii132–iii132. 1 indexed citations
8.
Yılmaz, Mürvet, et al.. (2016). Burnout Syndrome Among Hemodialysis and Peritoneal Dialysis Nurses.. PubMed. 10(6). 395–404. 25 indexed citations
9.
Yılmaz, Mürvet, et al.. (2016). Opinions about Death of Dialysis Patients. West Indian Medical Journal. 1 indexed citations
10.
Kırçelli, Fatih, Ercan Ok, Mürvet Yılmaz, et al.. (2016). Dialyzing women and men: does it matter? An observational study. Clinical Kidney Journal. 9(3). 486–493. 7 indexed citations
11.
Şahin, İrfan, Özlem Harmankaya, Mürvet Yılmaz, et al.. (2016). Decreased Serum 25-hydroxyvitamin D Level Causes Interventricular Septal Hypertrophy in Patients on Peritoneal Dialysis: Cardiovascular Aspects of Endogenous Vitamin D Deficiency. International Journal of Nephrology. 2016. 1–6.
12.
Öztürk, Musa, et al.. (2016). Interferon β associated nephropathy in a Multiple Sclerosis patient: A case and review. Multiple Sclerosis and Related Disorders. 9. 50–53. 13 indexed citations
13.
Harmankaya, Özlem, Yıldız Okuturlar, Hakan Koçoğlu, et al.. (2015). Renal biopsy in the elderly: a single-center experience. International Urology and Nephrology. 47(8). 1397–1401. 18 indexed citations
14.
Ateş, Mustafa, Sinan Hatipoğlu, Abuzer Dirican, et al.. (2013). Right-Lobe Living-Donor Liver Transplantation in Adult Patients With Acute Liver Failure. Transplantation Proceedings. 45(5). 1948–1952. 6 indexed citations
15.
Yılmaz, Mürvet, Abdülkadir Ünsal, Özlem Harmankaya, et al.. (2013). Renal Involvement in AA Amyloidosis: Clinical Outcomes and Survival. Kidney & Blood Pressure Research. 37(1). 33–42. 28 indexed citations
16.
Yılmaz, Mürvet, et al.. (2012). Inevitable hemodialysis for treating resistant hypertension in a patient with Leriche syndrome. Clinics. 67(12). 1483–1486. 2 indexed citations
17.
Yılmaz, Mürvet, et al.. (2012). The Prevalence of Hypertension, Valve Calcification and Left Ventricular Hypertrophy and Geometry in Peritoneal Dialysis Patients. Kidney & Blood Pressure Research. 35(6). 431–437. 11 indexed citations
18.
Yılmaz, Mürvet, Abdülkadir Ünsal, Özlem Harmankaya, et al.. (2011). Duodenal biopsy for diagnosis of renal involvement in amyloidosis. Clinical Nephrology. 77(2). 114–118. 13 indexed citations
19.
Koç, Yener, et al.. (2009). The retrospective evaluation of patients treated by hemodialysis for the first time. 43(4). 169–173. 1 indexed citations
20.
Harmankaya, Özlem, S. Seber, & Mürvet Yılmaz. (2003). Combination of Pentoxifylline with Angiotensin Converting Enzyme Inhibitors Produces an Additional Reduction in Microalbuminuria in Hypertensive Type 2 Diabetic Patients. Renal Failure. 25(3). 465–470. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoqiang Ding Breakdown of academic impact, for papers by Yoshiro Fujita Breakdown of academic impact, for papers by David Metz Breakdown of academic impact, for papers by Richard J. Johnson Breakdown of academic impact, for papers by Nuri Barış Hasbal Breakdown of academic impact, for papers by Sinan Trabulus Breakdown of academic impact, for papers by José Carlos Peña Breakdown of academic impact, for papers by Li Luo Breakdown of academic impact, for papers by Richard Hull Breakdown of academic impact, for papers by Sam James
Rankless by CCL
2026